The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Deciphera Pharmaceuticals, Inc(NASDAQ:DCPH) 
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies. Its lead drug candidate is QINLOCK used for the treatment ...
Deciphera Pharmaceuticals Days Payable Outstanding ttm (DPO)
Deciphera Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Deciphera Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Deciphera Pharmaceuticals Op Cashflow Per Share ttm
Deciphera Pharmaceuticals Free Cashflow Per Share ttm
Deciphera Pharmaceuticals Cash Per Share ttm
Deciphera Pharmaceuticals P/S ratio ttm
Deciphera Pharmaceuticals (GAAP) P/E ratio ttm
Deciphera Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.